#United States #Houston #TYBR Health #B3 GEL #Jeff Tyber

TYBR Health Welcomes Jeff Tyber to Board of Directors

On January 12, 2026, TYBR Health, a leader in regenerative medicine focused on enhancing post-surgical healing, proudly announced the appointment of Mr. Jeff Tyber to its Board of Directors. This strategic decision comes as TYBR Health accelerates efforts to address the critical needs in soft-tissue recovery following surgery.

A Wealth of Experience for a Pivotal Role

Tim Keane, PhD, Co-founder and CEO of TYBR Health, expressed his enthusiasm about Tyber's appointment, emphasizing the importance of his extensive experience. “We are thrilled to welcome Jeff Tyber to our Board of Directors at this pivotal moment in TYBR Health's growth trajectory,” he stated. Jeff’s historic acumen in building and scaling innovative medical device companies stands to provide invaluable insights as the company advances into its commercial growth phase.

Jeff Tyber is no stranger to the medical device landscape; he boasts over 25 years of management, engineering, regulatory, and operational expertise. As the founder and former CEO of Tyber Medical, which was recently acquired and restructured, he continues to contribute significantly as Group President and Board Member for Exalta Group. Tyber's previous ventures include serving as a co-founder of MedShape, Inc., and playing crucial roles in pioneering companies like Extremity Medical.

Innovative Solutions for Unmet Patient Needs

The primary focus of TYBR Health is its innovative B3 GEL™ System. This groundbreaking solution aims to provide clinical improvement in post-operative tendon mobility, proving to be a game changer in tissues recovery. The proprietary delivery system of B3 GEL™ is designed for seamless integration into existing surgical workflows, empowering surgeons to achieve superior functional outcomes.

Tyber commended the team's vision, stating, “TYBR Health is addressing a large unmet need in the post-operative tissue protection market with its first-to-market flowable, bioabsorbable B3 GEL™ System.” He highlighted that the simplicity and elegance of this approach can cater to both open and minimally invasive surgical procedures, ensuring optimal soft tissue protection, thus revolutionizing recovery methodologies.

Looking Ahead: A Commitment to Patient Recovery

Jeff Tyber emphasized his eagerness to support TYBR Health in its quest to enhance recovery for both surgeons and patients. By combining Tyber's vast operational knowledge with TYBR Health's innovative product offerings, the company aims to optimize recovery processes significantly.

In its mission, TYBR Health aspires to set new standards in post-surgical care, ensuring that patients experience improved recovery journeys through effective healing solutions. With the appointed leadership of Jeff Tyber, the company is poised to rise to new heights in delivering exceptional healthcare outcomes.

For more information about TYBR Health and its transformative solutions, visit www.tybrhealth.com. Typically recognized for its remarkable advancements in regenerative medicine, TYBR Health continues to challenge the norms surrounding post-surgical recovery.

For more media inquiries, reach out to:
Tim Keane
Co-Founder & CEO
TYBR Health
Email: [email protected]

As TYBR Health navigates this exciting chapter of innovation and growth with a robust Board of Directors, the future looks bright for advancements in the healing process, promising new horizons for surgical patients and healthcare providers alike.